| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0071 | 1 |